| | 2024 年 | 2023 年 | 本年比上年增减 | 2022 年 | | --- | --- | --- | --- | --- | | 营业收入(元) | 24,594,583.59 | 144,040,552.02 | -82.93% | 86,256,162.59 | | 归属于上市公司股东 的净利润(元) | -52.784.096.15 | -62.580.095.29 | 15.65% | -81,070,520.63 | | 的扣除非经常性损益 | -63.240.797.87 | -79,842,966.04 | 20.79% | -88.314.359.02 | | 的净利润(元) | | | | | | 经营活动产生的现金 流量净额(元) | -24.178.911.97 | -48.448.801.36 | 50.09% | 88.319.783.83 | | 归属于上市公司股东 | | | | | *ST和科于4月29日发布股票交易被实行退市风险警示暨停牌公告。公司股票自2025年4月30日起被实 施"退市风险警示"处理，股票简称由"和科达"变更为"*ST和科"，证券代码仍 ...

Summary of Key Points Core Viewpoint - *ST Suwu's stock price has significantly declined, with a drop of 14.76% this week, reaching a near one-year low, indicating potential financial distress and market volatility [1][3]. Trading Information Summary - As of May 16, 2025, *ST Suwu's stock closed at 2.31 yuan, down from 2.71 yuan the previous week, marking a 14.76% decrease - The stock reached a weekly high of 2.84 yuan on May 12 and a low of 2.26 yuan on May 16 - The company's total market capitalization is currently 1.645 billion yuan, ranking 148th out of 151 in the chemical pharmaceutical sector and 5022nd out of 5147 in the A-share market [1]. Company Announcement Summary - Chairman Qian Qunshan is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of securities laws and regulations related to information disclosure - The controlling shareholder, Suzhou Wuzhong Investment Holding Co., Ltd., holds 122,795,762 shares, accounting for 17.24% of the total share capital, with 94.48% of these shares pledged - The company has received a qualified audit report from Zhongxing Caiguanghua Accounting Firm for the 2024 fiscal year, indicating issues with non-operating fund occupation by related parties - The stock has been placed under delisting risk warning (ST) and other risk warnings due to significant price fluctuations exceeding 12% over three consecutive trading days [1][3].

证券代码：000638 证券简称：*ST 万方 公告编号：2025-034 万方城镇投资发展股份有限公司 本公司及其董事会全体成员保证信息披露内容的真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 被实施退市风险警示暨停牌的公告》， 2024 年度经审计扣除非经常性损益后的净 利润为负值，且扣除后的营业收入低于 3 亿元。根据《深圳证券交易所股票上市 （2024 年修订）第 9.34 条的规定，自 2025 年 4 月 30 日公司股票交易被实 规则》 易被实施退市风险警示暨停牌的公告》， 2024 年度经审计扣除非经常性损益后 的净利润为负值，且扣除后的营业收入低于 3 亿元。根据《深圳证券交易所股票 上市规则》（2024 年修订）第 9.34 条的规定，自 2025 年 4 月 30 日公司股票交 易被实施退市风险警示（股票简称前冠以"*ST"字样），敬请广大投资者注意 投资风险。 一、股票交易异常波动情况 公司股票连续三个交易日（2025 年 5 月 13 日至 2025 年 5 月 15 日）收盘价 格涨幅累计偏离值累计为 16.99％，根据《深圳证券交易所交易规则》（2023 年 ...

风波中的上海贵酒再迎高管变动。 公司董事长韩啸于去年9月被公安机关采取刑事强制措施，目前仍处于羁押状态。如今，公司副董事长陈琪又因个人 原因请辞，公司需要尽快确定代行董事长职责的人选。 5月14日，记者自上海贵酒证券部门工作人员处获悉，代行董事长职责的人选预计在本月23日左右确定。 现如今的上海贵酒，困难重重：董事长因处于羁押状态无法正常履职、公司过半股票被司法冻结、公司去年业绩亏 损、今年一季度继续亏损……公司股票于2025年4月23日起被实施退市风险警示。 管理层频繁变动： 董事长被羁押、副董事长请辞 5月13日晚间，上海贵酒（公司全称为上海贵酒股份有限公司，股票简称为岩石股份）发布公告称陈琪因个人原因申 请辞去公司副董事长的职务。辞去副董事长职务后，陈琪仍担任公司董事并代行董事会秘书的职责。 需要注意的是，因公司董事长韩啸被公安机关采取刑事强制措施，无法正常履职，根据相关规定由副董事长陈琪代 行董事长职责。现因陈琪申请辞去副董事长职务，公司将尽快确定代行董事长职责的人选，在人选确认之前，陈琪 仍代行董事长的职责。 上海贵酒2024年财报显示，韩啸因被公安机关采取刑事强制措施，目前处于羁押状态。公司控股股 ...

Core Viewpoint - The ongoing disputes between former executives of Gengxing Co., Ltd. (currently *ST Gengxing, SH600753) and the company have resurfaced, primarily due to unresolved compensation issues following their departures [1][2][3] Group 1: Disputes and Legal Actions - Multiple former executives, including the former general manager and vice general manager, have initiated arbitration or lawsuits against Gengxing Co., Ltd. due to unpaid severance [1][2][7] - As of March 25, 2025, an arbitration court ruled that Gengxing Co., Ltd. must pay severance to former financial center deputy director Zhou Wenyang, but the company has contested this ruling [2][3] - The company has faced a total of 10 labor contract disputes, with some cases already settled for a total of 272,000 yuan [3][4][12] Group 2: Financial Performance - In 2024, Gengxing Co., Ltd. reported a revenue of 410 million yuan, a decrease of 49.87% year-on-year, and a net loss of 236 million yuan, which is a 357.42% increase in losses compared to the previous year [12][15] - The company’s total assets decreased by 64.82% to approximately 162 million yuan by the end of 2024, and it has been under delisting risk warning since April 29, 2025, due to negative net profits for three consecutive years [12][15] Group 3: Management Changes and Business Strategy - Following the acquisition of shares by Zhejiang Haixin Energy, the new management team has shifted the company's focus from traditional coal business to liquefied petroleum gas (LPG) distribution [15] - In the fourth quarter of 2024, Gengxing Co., Ltd. achieved a total revenue of 404 million yuan from commodity supply chain operations, with LPG-related revenue being a new addition [15][16]

Core Viewpoint - The chairman of *ST Suwu is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact the company's financial reporting and operations in the future [1][2]. Group 1: Investigation and Regulatory Actions - The CSRC has issued a notice of investigation against chairman Qian Qunshan, which is solely directed at him and is not expected to significantly affect the company's daily operations [1]. - The company has received a non-standard opinion on its 2024 annual report due to issues related to the occupation of funds, with a significant amount of 769 million yuan occupied by related parties [4]. - The company will provide weekly updates on the investigation's progress during the ongoing inquiry [2]. Group 2: Financial Performance - For the year 2024, *ST Suwu reported a revenue of 1.599 billion yuan, representing a year-on-year decrease of 28.64%, and a net profit attributable to shareholders of 70.48 million yuan [4]. - The company has received an audit report from Zhongxing Caiguanghua Accounting Firm that expresses an inability to provide an opinion on the financial statements due to the aforementioned issues [4]. Group 3: Business Operations and Strategy - *ST Suwu operates in the pharmaceutical sector through its wholly-owned subsidiary, Jiangsu Wuzhong Pharmaceutical Group, focusing on drug research, production, and sales, with key products in various therapeutic areas [2]. - The company aims to develop a dual-driven strategy focusing on both industrial development and capital operations, with plans to enhance its pharmaceutical core while nurturing the medical beauty biotechnology sector as a complementary industry [4]. Group 4: Legal and Financial Challenges - The company’s subsidiary, Jiangsu Wuzhong Import and Export Co., faced legal issues related to export tax fraud, with a court hearing scheduled for April 22, 2025 [5]. - Due to overdue loans, some of the company's bank accounts have been frozen, which may further impact its financing capabilities and business operations [5].

Group 1 - The company's stock experienced abnormal trading fluctuations, with a cumulative price increase deviation exceeding 12% over three consecutive trading days [1] - The company conducted necessary verifications regarding the abnormal price fluctuations and confirmed that there are no undisclosed significant matters affecting the stock price [1] - The board of directors stated that there are no significant undisclosed matters or ongoing negotiations that should be disclosed according to the Shenzhen Stock Exchange regulations [1] Group 2 - The company has been subject to delisting risk warnings due to its operating income falling below 300 million yuan, leading to a change in its stock name to "*ST Guohua" and a trading limit of 5% [2] - The company has designated specific media outlets for information disclosure, emphasizing the importance of rational investment and risk awareness for investors [2]

Core Viewpoint - Shanghai Jiubai has not disclosed the announcement for the re-election of its board of directors and supervisory board, indicating that the current board has been in office for four months beyond its term [1][7] - The company's 2024 annual report shows a revenue of 92.70 million yuan, a year-on-year increase of 7.11%, but a net profit attributable to shareholders of 42.03 million yuan, a year-on-year decrease of 32.42% [1][2] Financial Performance - Shanghai Jiubai's revenue has remained below 100 million yuan for ten consecutive years, placing it at the bottom of the retail sector among A-share listed companies [2][3] - The company achieved a net profit of over 42 million yuan despite its low revenue, primarily due to investment income from joint ventures [2][3] - The main sources of profit are from joint ventures, specifically Shanghai Jiuguang Department Store and Shanghai Jiubai City Square, which contributed significant investment income [3][4] Subsidiary Performance - The wholly-owned subsidiary, Shanghai Zhengzhang Laundry Co., has reported losses for 11 consecutive years, accumulating a total loss of 121.9 million yuan [5][6] - Shanghai Jiubai has a significant amount of other receivables from Zhengzhang Laundry, totaling 151 million yuan, which accounts for 83.99% of the company's total other receivables [5][6] - Despite the ongoing losses from Zhengzhang Laundry, the company has not made substantial progress in improving its core business performance [6][7] Governance and Future Outlook - The current board's term has been extended, and there is uncertainty regarding the new board's ability to address the ongoing issues with the subsidiary and improve revenue [1][7] - The company has not disclosed any updates on the new board members as of May 13, 2024, raising concerns about its governance and strategic direction [1][7]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000691 证券简称：*ST亚太（维权） 公告编号：2025-043 甘肃亚太实业发展股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、股票交易异常波动的情况介绍 甘肃亚太实业发展股份有限公司（以下简称"公司"或"本公司"）的股票（证券简称：*ST亚太 ，证券代 码：000691）连续3个交易日（2025 年5月8日、2025 年5月9日、2025 年5月12日）收盘价格涨幅偏离值 累计超过12%。根据《深圳证券交易所交易规则》的规定，属于股票交易异常波动的情形。 二、公司关注并核实情况说明 针对公司股票价格异常波动情况，公司进行了全面自查，并询问了公司控股股东及实际控制人，现将有 关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司于2025年2月10日披露了《关于深圳证券交易所同意公司撤回向特定对象发行股票申请文件的公 告》（公告编号：2025-011）。经公司第九届董事会第十次会议及第九届监事会第七次会议审议，公司 同意终止向特定对 ...

证券代码：600228 证券简称：*ST 返利 公告编号：2025-038 返利网数字科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 返利网数字科技股份有限公司（以下简称"公司"）股票价格于 2025 年 5 月 8 日、2025 年 5 月 9 日、2025 年 5 月 12 日连续 3 个交易日内日收盘价格涨幅偏 离值累计超过 12%，根据《上海证券交易所交易规则》的相关规定，属于股票交 易异常波动情形。 ? 经公司董事会自查及发函问询控股股东及实际控制人，截至本公告披露日， 除公司已披露的事项外，公司、控股股东及实际控制人确认不存在其他应披露而未 披露的重大信息。 ? 风险提示详见本公告"三、相关风险提示"，公司敬请广大投资者注意风险， 理性决策，审慎投资。 一、公司股票交易异常波动的具体情况 公司股票价格于 2025 年 5 月 8 日、2025 年 5 月 9 日、2025 年 5 月 12 日连续三 个交易日内日收盘价格涨幅偏离值累计超过 12%，根据《上海证券 ...